Cargando…

Diagnosing EVALI in the Time of COVID-19

Detalles Bibliográficos
Autores principales:	Callahan, Sean J., Harris, Dixie, Collingridge, Dave S., Guidry, David W., Dean, Nathan C., Lanspa, Michael J., Blagev, Denitza P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Chest Physicians 2020
Materias:	Diffuse Lung Disease: Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319621/ https://www.ncbi.nlm.nih.gov/pubmed/32599069 http://dx.doi.org/10.1016/j.chest.2020.06.029

Ejemplares similares

Autopsy insights from the EVALI epidemic
por: Blagev, Denitza P, et al.
Publicado: (2020)

OUTCOMES IN PATIENTS WITH SARCOIDOSIS DIAGNOSED WITH COVID-19
por: NADEEM, OWAIS, et al.
Publicado: (2021)

Alveolar macrophages from EVALI patients and e-cigarette users: a story of shifting phenotype
por: Warren, Kristi J., et al.
Publicado: (2023)

A CASE OF SEVERE E-CIGARETTE OR VAPING PRODUCT USE-ASSOCIATED LUNG INJURY IN THE TIME OF COVID-19
por: WASSERMAN, EVAN, et al.
Publicado: (2021)

DERMATOMYOSITIS AFTER COVID-19 PNEUMONIA
por: KHANAM, VERISHA, et al.
Publicado: (2022)

COVID-19 VACCINE-RELATED PNEUMONITIS
por: TSENG, CHENGTIN, et al.
Publicado: (2022)

PUTTING THE "SARS” IN "SARS-COVID-19": A CASE OF SARCOID-LIKE INFLAMMATORY REACTION AFTER COVID-19 VACCINATION
por: JAFRI, MUSTAFA HUS, et al.
Publicado: (2022)

A REMINDER OF THE EXISTENCE OF EVALI IN THE TIME OF COVID-19
por: WASSERMAN, EVAN, et al.
Publicado: (2021)

MULTISYSTEM SARCOIDOSIS ASSOCIATED WITH THE COVID-19 MRNA VACCINE
por: MITMA, ANGEL A, et al.
Publicado: (2022)

COVID-19 VACCINE UPTAKE IN AN INTERSTITIAL LUNG DISEASE CLINIC
por: LEAHY, AMY, et al.
Publicado: (2021)

ORGANIZING PNEUMONIA AS A SIDE EFFECT OF COVID-19 VACCINE
por: DADHWAL, R., et al.
Publicado: (2022)

NOT ALL ARDS IS COVID: THE RISK OF PREMATURE CLOSURE AND THE VALUE OF MULTIDISCIPLINARY DISCUSSION
por: VARGAS, JORGE, et al.
Publicado: (2021)

THINKING BEYOND COVID-19: A CASE OF KRATOM-INDUCED PNEUMONITIS
por: MINICH, CORBYN, et al.
Publicado: (2021)

ORGANIZING PNEUMONIA FOLLOWING COVID-19: A REPORT OF 8 CASES
por: BETHLEM, MARCOS, et al.
Publicado: (2021)

EXTENSION OF STEROID THERAPY FOR POST-COVID-19 FIBROTIC LUNG SEQUALAE
por: TOUMAN, A., et al.
Publicado: (2022)

PREDICTORS OF POST-COVID-19 PULMONARY FIBROSIS: A CASE SERIES
por: CÎRJALIU, R.-E., et al.
Publicado: (2022)

MORTALITY AND ITS PREDICTORS IN PATIENTS WITH COVID-19 WITH PREEXISTING INTERSTITIAL LUNG DISEASE
por: DUTT, N., et al.
Publicado: (2022)

COVID-19 PNEUMONIA AND PERICARDITIS IN A PATIENT WITH UNTREATED CYSTIC LUNG DISEASE
por: KOZLIK, ANN, et al.
Publicado: (2022)

AGGRESSIVE AND RAPID NASCENT HONEY COMBING DURING ACUTE COVID-19 INFECTION: A CASE REPORT
por: JOSHI, V., et al.
Publicado: (2022)

PULMONARY ALVEOLAR PROTEINOSIS SUBMITTED A WHOLE LUNG LAVAGE AFTER COVID-19: A CASE REPORT
por: D'AMBROSIO, PAULA, et al.
Publicado: (2021)

A CASE REPORT OF COMPLICATIONS IN A SURVIVOR OF SEVERE COVID-19: PULMONARY FIBROSIS AND LONG-TERM SUPPLEMENTAL OXYGEN REQUIREMENT
por: YANAMADALA, A.
Publicado: (2022)

A CASE OF SEVERE HYPOXEMIA AND HEMOPTYSIS SECONDARY TO E-CIGARETTE AND VAPING PRODUCT USE-ASSOCIATED LUNG INJURY IN COVID-19 ERA
por: POLISETTY, LAKSHMI, et al.
Publicado: (2021)

ELECTRONIC VAPE-ASSOCIATED LUNG INJURY: A UNIQUE PRESENTATION
por: Hawk, Fahad, et al.
Publicado: (2020)

FIBROTIC PROTEASE 3 ANCA-ASSOCIATED VASCULITIS
por: Megri, Mohammed, et al.
Publicado: (2020)

CHILDHOOD-ONSET INTERSTITIAL LUNG DISEASE: A RARE CASE OF IDIOPATHIC, NONSPECIFIC INTERSTITIAL PNEUMONIA IN A TEENAGER
por: Cerro, Giuliana, et al.
Publicado: (2020)

AN UNUSUAL PRESENTATION OF NONSPECIFIC INTERSTITIAL PNEUMONIA
por: Matta, Atul, et al.
Publicado: (2020)

THE PERFECT STORM: DIFFUSE ALVEOLAR HEMORRHAGE AFTER SARS-COV-2 INFECTION
por: WANG, EDWARD, et al.
Publicado: (2021)

A CASE OF STEROID RESPONSIVE SEVERE PNEUMONIA RELATED TO IMMUNE-LIKE RECONSTITUTION INFLAMMATORY RESPONSE 3 MONTHS AFTER RITUXIMAB THERAPY FOR PEDIATRIC AUTOIMMUNE NEUROPSYCHIATRIC DISORDER ASSOCIATED WITH STREPTOCOCCAL INFECTIONS
por: POURSHAHID, SEYEDMOHAMMAD, et al.
Publicado: (2021)

WITHDRAWN
Publicado: (2022)

CHALLENGES IN DIAGNOSIS AND MANAGEMENT OF EVALI IN THE COVID-19 ERA: A SYSTEMATIC REVIEW
por: AYAZ AHMED, MUBASHIR, et al.
Publicado: (2021)

LOOKING AT THE GROUND GLASS THROUGH COVID-19 COLORED GLASSES: A CASE OF EVALI AMIDST THE COVID-19 PANDEMIC
por: JAGROOP, NIA, et al.
Publicado: (2021)

COVID-19 in Lymphangioleiomyomatosis: An International Study of Outcomes and Impact of Mechanistic Target of Rapamycin Inhibition
por: Baldi, Bruno Guedes, et al.
Publicado: (2022)

The Use of Genetic Information to Define Idiopathic Pulmonary Fibrosis in UK Biobank
por: Leavy, Olivia C., et al.
Publicado: (2023)

Disparities in Rural Populations With Idiopathic Pulmonary Fibrosis
por: DeDent, Alison M., et al.
Publicado: (2022)

Practical Considerations for the Diagnosis and Treatment of Fibrotic Interstitial Lung Disease During the Coronavirus Disease 2019 Pandemic
por: Wong, Alyson W., et al.
Publicado: (2020)

EVALI IN THE ERA OF COVID-19
por: PUTHUMANA, ROSE, et al.
Publicado: (2021)

Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi Study
por: Rahaghi, Franck F., et al.
Publicado: (2022)

Laboratory-based Intermountain Validated Exacerbation (LIVE) Score stability in patients with chronic obstructive pulmonary disease
por: Blagev, Denitza P, et al.
Publicado: (2020)

Lung Transplantation for Patients With COVID-19
por: King, Christopher S., et al.
Publicado: (2022)

Early Radiographic Progression of Scleroderma: Lung Disease Predicts Long-term Mortality
por: Volkmann, Elizabeth R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bnggsikqbb223091jqa34f19u3